Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

It used to be that Chinese drug development was largely about creating "me too" drugs for the local market. But over the past ...

Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound ... telehealth company improperly referenced Lilly's approved drugs and clinical trials on its website in order to ...

Eli Lilly, the drugmaker behind the blockbuster weight loss ... available drug. Mochi representatives did not respond to requests for comment. Lilly's complaint against Henry Meds alleges the ...